The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a ...

Ozempic and Wegovy ... Trump administration’s approach to the negotiation process and the type of Medicare drug coverage an enrollee has. Those not eligible for Medicare will not benefit ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of ...

Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy ... also proposed expanding Medicare coverage to weight loss drugs, which ...

Those drugs are: Ozempic/Wegovy/Rybelsus ... About 5.3 million people with Medicare prescription drug coverage used these medications from November 2023 through October 2024 at a cost of $ ...